Modification of 24-h ambulatory blood pressure and heart rate during contraception with the vaginal ring: A prospective study

Contraception

Volumn 88, Issue 4, 2013, Pages 539-543

  Cagnacci, Angelo ^a   Zanin, Renata ^a   Napolitano, Antonella ^a   Arangino, Serenella ^b   Volpe, Annibale ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b AUSL Modena   (Italy)

Author keywords

Blood pressure; Diurnal, Ambulatory monitoring; Heart rate, Hypertension; Vaginal contraception

Indexed keywords

ETHINYLESTRADIOL; ETONOGESTREL;

ADULT; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLICULAR PHASE; HEART RATE; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; PROSPECTIVE STUDY; RISK FACTOR; VAGINA CONTRACEPTION; VAGINA RING;

BLOOD PRESSURE; DIURNAL, AMBULATORY MONITORING; HEART RATE, HYPERTENSION; VAGINAL CONTRACEPTION;

ADMINISTRATION, INTRAVAGINAL; ADULT; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE DEVICES, FEMALE; DELAYED-ACTION PREPARATIONS; DESOGESTREL; DRUG COMBINATIONS; ESTROGENS; ETHINYL ESTRADIOL; FEMALE; FOLLICULAR PHASE; HEART RATE; HUMANS; HYPERTENSION; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84884205084     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2013.04.003     Document Type: Article

References (44)

1. P.M. Kearney, M. Whelton, K. Reynolds, P. Muntner, P.K. Whelton, and J. He Global burden of hypertension: analysis of worldwide data Lancet 365 2005 217 223
2. D. Conen, P.M. Ridker, J.E. Buring, and R.J. Glynn Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study BMJ 335 2007 432
3. S. Lewington, R. Clarke, N. Qizilbash, R. Peto, and R. Collins Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies Lancet 360 2002 1903 1913
4. D. Levy, M.G. Larson, R.S. Vasan, W.B. Kannel, and K.K. Ho The progression from hypertension to congestive heart failure JAMA 275 1996 1557 1562
5. R.S. Vasan, A. Beiser, and S. Seshadri Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study JAMA 287 2002 1003 1010
6. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception: ischaemic stroke and combined oral contraceptives: results of an international multicentre case control study Lancet 348 1996 498 505
7. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception: haemorragic stroke, overall stroke risk, and combined oral contraceptives: results of an international multicentre case-control study Lancet 348 1996 505 510
8. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception: acute myocardial infarction and combined oral contraceptives: results of an international multicentre case control study Lancet 349 1997 1202 1209
9. Centers for Disease Control and Prevention. U.S. Medical Eligibility Criteria for Contraceptive Use, 2010 MMWR Recomm Rep 59 2010 1 86
10. R.J. Weir, E. Briggs, A. Mack, L. Naismith, L. Taylor, and E. Wilson Blood pressure in women taking oral contraceptives Br Med J 1 1974 533 535
11. I.R. Fisch, and J. Frank Oral contraceptives and blood pressure JAMA 237 1977 2499 2503
12. E.S.B. Wilson, J. Cruickshank, M. McMaster, and R.J. Weir A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen J Obstet Gynaecol 91 1984 1254 1260
13. K. Narkiewicz, G.R. Graniero, D. D'Este, M. Mattarei, P. Zonzin, and P. Palatini Ambulatory blood pressure in mild hypertensive women taking oral contraceptives. A case-control study Am J Hypertens 8 1995 249 253
14. R.J. Weir Effect on blood pressure of changing from high to low dose steroid preparations in women with oral contraceptive induced hypertension Scott Med J 27 1982 212 215
15. N. Fuchs, B. Dusterberg, F. Weber-Diehl, and B. Muhe The effect on blood pressure of a monophasic oral contraceptive containing ethinylestradiol and gestodene Contraception 51 1995 335 339
16. I.F. Godsland, D. Crook, M. Devenport, and V. Wynn Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease Contraception 52 1995 143 149
17. K. Fox, J.S. Borer, J. Camm for the heart rate working group Resting heart rate in cardiovascular disease J Am Coll Cardiol 50 2007 823 830
18. F. Custodis, S.H. Schirmer, M. Baumhakel, G. Heusch, M. Bohm, and U. Laufs Vascular pathophysiology in resonse to increased heart rate J Am Coll Cardiol 56 2010 1973 1983
19. C.V. Asche, J. Kim, A.S. Kularni, P. Chakravarti, and K.-E. Andersson Assessment of association of increased heart rates to cardiovascular events among healthy subjects in the United States: analysis of primary care electronic medical records database 2011 ISRN Cardiology http://dx.doi.org/10.5402/2011/ 924343
20. A. Cagnacci, S. Ferrari, A. Napolitano, I. Piacenti, S. Arangino, and A. Volpe Combined oral contraceptive containing drospirenone does not modify 24-h ambulatory blood pressure but increases heart rate in healthy young women: prospective study Contraception 2012 Dec 10. doi:pii: S0010-7824(12)01033-5. 10.1016/j.contraception.2012.12.002
21. M.W. Van den Heuvel, A.J. van Bragt, A.K. Alnabawy, and M.C. Kaptein Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive Contraception 72 2005 168 174
22. A.M. Mohamed, W.S. El-Sherbiny, and W.A. Mostafa Combined contraceptive ring versus combined oral contraceptive (30-μg ethinylestradiol and 3-mg drospirenone) Int J Gynaecol Obstet 114 2011 145 148
23. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)Guidelines for the management of arterial Hypertension Eur Heart J 28 2007 1462 1536
24. A. Cagnacci, F. Baldassari, S. Arangino, C. Alessandrini, and A. Volpe Administration of tibolone decreases 24-h heart rate but not blood pressure of post-menopausal women Maturitas 48 2004 155 160
25. Y.K. Tu, and M.S. Gilthorpe Revisiting the relation between change and initial value: a review and evaluation Stat Med 26 2007 443 457
26. M. Luque-Ramírez, C. Mendieta-Azcona, F. Alvarez-Blasco, and H.F. Escobar-Morreale Effects of metformin versus ethinyl-estradiol plus cyproterone acetate on ambulatory blood pressure monitoring and carotid intima media thickness in women with the polycystic ovary syndrome Fertil Steril 91 2009 2527 2536
27. N.E. Straznicky, V.E. Barrington, P. Branley, and W.J. Louis A study of the interactive effects of oral contraceptive use and dietary fat intake on blood pressure, cardiovascular reactivity and glucose tolerance in normotensive women J Hypertens 16 1998 357 368
28. W. Oelkers Antimineralocorticoid activity of a novel oral contraceptive containing drospirenone, a unique progestogen resembling natural progesterone Eur J Contracept Reprod Health Care 7 2002 19 26
29. W.K. Oelkers Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure Steroids 61 1996 166 171
30. S.Z. Goldhaber, H. Charles, and Hennekens Plasma renin substrate, renin activity, and aldosterone levels in a sample of oral contraceptive users from a community survey Am Heart J 107 1984 119 122
31. R. Sitruk-Ware, G. Plu-Bureau, and J. Menard Effects of oral and transvaginal ethinyl estradiol on hemostatic factors and hepatic proteins in a randomized, crossover study J Clin Endocrinol Metab 92 2007 2074 2079
32. A.H. Ahmed, R.D. Gordon, P.J. Taylor, G. Ward, E. Pimenta, and M. Stowasser Effect of contraceptives on aldosterone/renin ratio may vary according to the components of contraceptive, renin assay method, and possibly route of administration J Clin Endocrinol Metab 96 2011 1797 1804
33. K.J. O'Connell, L.M. Osborne, and C. Westhoff Measured and reported weight change for women using a vaginal contraceptive ring vs a lowdose oral contraceptive Contraception 72 2005 323 327
34. K. Oddsson, B. Leifels-Fischer, and N.R. de Melo Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial Contraception 71 2005 176 182
35. F.J.M.E. Roumen, D. Apter, and T.M.T. Mulders Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol Hum Reprod 16 2001 469 475
36. H.J. Ahrendt, I. Nisand, and C. Bastianelli Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 μg ethinyl estradiol and 3 mg of drospirenone Contraception 74 2006 451 457
37. F.J.M.E. Roumen, and T.O.M. Dieben Comparison of uterine concentrations of ethinylestradiol and etonogestrel - after use of a contraceptive vaginal ring and an oral contraceptive Fertil Steril 85 2006 57 62
38. C. Battaglia, F. Mancini, and R. Fabbri Polycystic ovary syndrome and cardiovascular risk in young patients treated with drospirenone-ethinylestradiol or contraceptive vaginal ring. A prospective, randomized, pilot study Fertil Steril 94 2010 1417 1425
39. J.A. Hodgkinson, J.P. Sheppard, and C. Heneghan Accuracy of ambulatory blood pressure monitors: a systematic review of validation studies J Hypertens 31 2013 239 250
40. F. Cardoso, J. Polónia, A. Santos, J. Silva-Carvalho, and J. Ferreira-de-Almeida Low-dose oral contraceptives and 24-hour ambulatory blood pressure Int J Gynaecol Obstet 59 1997 237 244
41. N.K. Tepper, K.M. Curtis, M.W. Steenland, and P.A. Marchbanks Blood pressure measurement prior to initiating hormonal contraception: a systematic review Contraception 2012 doi:pii: S0010-7824(12)00754-8. 10.1016
42. Z. Barrett-O'Keefe, M.A. Witman, and J. McDaniel Angiotensin II potentiates α-adrenergic vasoconstriction in the elderly Clin Sci (Lond) 124 2013 413 422
43. G. Grassi, C. Turri, R. Dell'Oro, M.L. Stella, G.B. Bolla, and G. Mancia Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension J Hypertens 16 1998 1789 1796
44. P. Palatini Heart rate as a cardiovascular risk factor: do women differ from men? Ann Med 33 2001 213 221